Literature DB >> 1683870

Dimerization of internalized epidermal growth factor receptors.

A Sorkin1, G Carpenter.   

Abstract

Binding of epidermal growth factor (EGF) to cell surface EGF receptors initiates the formation of the receptor homodimers that can be detected by covalent cross-linking in intact cells or in detergent-solubilized cell extracts. Low pH dissociation of EGF from surface receptors results in immediate monomerization of receptor dimers. Using chemical cross-linking during mild permeabilization or cell solubilization, we have detected dimers of internalized EGF receptors in human carcinoma A-431 cells and transfected NIH 3T3 cells that express human EGF receptors. The percentage of internalized cross-linked receptor dimers was similar to that observed for surface EGF receptors. Furthermore, at the time of maximal accumulation of EGF-receptor complexes within the endosomal compartment (10-15 min of incubation at 37 degrees C), both the dimeric and monomeric forms of the EGF receptor are tyrosine-phosphorylated to the same extent as surface dimer and monomer species. In transfected NIH 3T3 cells, the level of dimerized and internalized kinase-negative EGF receptors was not different from that observed for wild-type receptors. These data suggest that for some time after internalization EGF does not dissociate from its receptor and indicate that a receptor conformation is preserved intracellularly that allows maintenance of receptor-receptor interactions and tyrosine kinase activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683870

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity.

Authors:  W Tsai; A D Morielli; E G Peralta
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

2.  Analysis of epidermal growth factor receptor dimerization by BS³ cross-linking.

Authors:  Harmony F Turk; Robert S Chapkin
Journal:  Methods Mol Biol       Date:  2015

3.  Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells.

Authors:  Xuejun Jiang; Alexander Sorkin
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

4.  Antibody-promoted dimerization bypasses the regulation of DNA binding by the heme domain of the yeast transcriptional activator HAP1.

Authors:  L Zhang; O Bermingham-McDonogh; B Turcotte; L Guarente
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 5.  Regulation of VEGF signaling by membrane traffic.

Authors:  Arie Horowitz; Himabindu Reddy Seerapu
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

6.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Authors:  Jianying Dong; Lee K Opresko; William Chrisler; Galya Orr; Ryan D Quesenberry; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

7.  Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

Authors:  S M Hernández-Sotomayor; C L Arteaga; C Soler; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 8.  Endocytosis and intracellular trafficking of ErbBs.

Authors:  Alexander Sorkin; Lai Kuan Goh
Journal:  Exp Cell Res       Date:  2008-08-28       Impact factor: 3.905

9.  Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis.

Authors:  Hua-Bei Guo; Heather Johnson; Matthew Randolph; Intaek Lee; Michael Pierce
Journal:  Glycobiology       Date:  2009-02-18       Impact factor: 4.313

10.  Implications of epidermal growth factor (EGF) induced egf receptor aggregation.

Authors:  C Wofsy; B Goldstein; K Lund; H S Wiley
Journal:  Biophys J       Date:  1992-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.